IPHC 2022 · Oral“Mediation Analysis of the Efficacy of the Nimotuzumab cisplatin radiation (NCR) Improve Overall Survival (OS) A HPV negative oropharyngeal cancer patient (HPVNOCP) cohort”
IPHC 2022 · Oral“A study on the deviation of effect sizes assumed while designing Phase III Randomised Controlled Trials”